Non-operating income (expense) for the nine month period ending September 30, 2007 and 2006 were $135,390, and $(4,029), respectively. The largest factor influencing the increase in 2007 relates to interest income derived from our higher cash deposit balance compared to prior period.
STATEMENTS OF OPERATIONS
Three Months Ended Nine Months Ended
Sept 30, Sept. 30,
2007 2006 2007 2006
Revenues $45,733 $150,072 $306,057 $209,283
Operating expenses
Research and development
costs 672,101 422,794 2,202,670 1,247,386
General, selling and
administrative expenses 832,348 311,932 2,359,515 763,664
Depreciation and
amortization 22,403 12,154 48,365 38,942
1,526,852 746,880 4,610,550 2,049,992
Operating loss (1,481,119) (596,808) (4,304,493)(1,840,709)
Nonoperating income (expense)
Interest 59,397 24,218 136,358 61,381
Interest expense (298) (394) (968) (9,090)
Reversal of Loss related
to adjustment of warrants
liability to fair value - 388,401 - -
Other expense - (26,505) - (56,320)
Net loss (1,422,020) (211,088) (4,169,103)(1,844,738)
Net loss per share,
basic (0.05) (0.01) (0.15) (0.08)
Average number of
shares of common
stock outstanding 29,372,895 25,608,272 28,370,589 24,591,149
BALANCE SHEET
'/>"/>
| SOURCE Neuralstem Inc. Copyright©2007 PR Newswire. All rights reserved |